Cargando…
The Influence of Cardiovascular Risk Factors and Hypogonadism on Cardiac Outcomes in an Aging Population of Beta-Thalassemia Patients
Beta-thalassemia major (β-TM) is a hereditary genetic disease worsened by many comorbidities due to transfusion-related iron despite chelation therapy. Since there has recently been an increase in life expectancy of patients to up to 50 years old, which influences the prevalence of these diseases an...
Autores principales: | Barbero, Umberto, Ajassa, Matteo, Gaglioti, Carmen Maria, Piga, Antonio, Ferrero, Giovanni Battista, Longo, Filomena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781644/ https://www.ncbi.nlm.nih.gov/pubmed/35050213 http://dx.doi.org/10.3390/jcdd9010003 |
Ejemplares similares
-
Exercise Stress Echocardiography with Tissue Doppler Imaging (TDI) Detects Early Systolic Dysfunction in Beta-Thalassemia Major Patients without Cardiac Iron Overload
por: Barbero, Umberto, et al.
Publicado: (2012) -
Does Hepcidin Tuning Have a Role among Emerging Treatments for Thalassemia?
por: Longo, Filomena, et al.
Publicado: (2022) -
Ineffective Erythropoiesis in β-Thalassaemia: Key Steps and Therapeutic Options by Drugs
por: Longo, Filomena, et al.
Publicado: (2021) -
Hypogonadism in thalassemia major patients
por: Srisukh, Sasima, et al.
Publicado: (2016) -
Pharmacological and clinical evaluation of deferasirox formulations for treatment tailoring
por: Piolatto, Andrea, et al.
Publicado: (2021)